LMI Projects and Activities
- Control and Prevention of Malaria (CAP-M) Project: USAID’s CAP-M program (2011 – 2016) supports community-based malaria prevention and treatment activities in the border areas of Myanmar, Thailand and Cambodia. The objective is to reduce high malaria transmission rates and to prevent the spread of resistance to widely used malaria treatment drugs. The program focuses on those most likely to contract malaria and who lack access to public health services, including seasonal laborers, forest workers, and migrants. Interventions include commodity support (treated bed nets, diagnostic kits, and treatment drugs), behavior change communication, and technical assistance on diagnosis, case management, and surveillance of drug resistant strains. Visit the Control and Prevention of Malaria (CAP-M) Program website to find out more.
- Drug Quality Monitoring in Greater Mekong sub-region: This USAID-funded program provides support to LMI partner countries for the control and regulation of counterfeit and substandard medicines. The program monitors the quality of drugs used to treat malaria, tuberculosis, HIV and AIDS and other infectious diseases. Please click here for more information on promoting the quality of medicines in the region.
- Emerging Pandemic Threats (EPT) program: USAID’s EPT program (2011 – 2015) promotes early identification of and response to dangerous pathogens in animals before they can become threats to human health. Leveraging the expertise of joint human, animal, and wildlife sectors, EPT is strengthening disease outbreak detection, fostering joint outbreak investigations and response, and building capacity of academic and national human and veterinary diagnostic laboratories in LMI partner countries to screen for diseases. Visit the global EPT program website to find out more.
- Promoting the Quality of Medicines (PQM): This activity provides technical assistance to LMI partner countries in controlling and regulating counterfeit and substandard medicines. The program monitors the quality of drugs used for malaria, tuberculosis, and other infectious diseases treatment in the Lower Mekong sub-region. The activity supports two centers of excellence in Thailand, which provide technical assistance in drug quality assurance and related activities on product manufacturing standards. Visit the PQM website managed by the U.S. Pharmacopeial Convention for more information.